Background: Despite the high success rate of bronchial artery embolization (BAE), hemoptysis probably recurs. This study investigated risk factors of 12-month hemoptysis recurrence after BAE in an Iranian population.
Methods: In this prospective cohort, we followed up 101 patients for 12 months after BAE.